245 related articles for article (PubMed ID: 32399811)
1. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis.
Sheikh P; Lohsiriwat V; Shelygin Y
Adv Ther; 2020 Jun; 37(6):2792-2812. PubMed ID: 32399811
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
3. Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease.
Godeberge P; Sheikh P; Lohsiriwat V; Jalife A; Shelygin Y
J Comp Eff Res; 2021 Jul; 10(10):801-813. PubMed ID: 33928786
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of micronized purified flavonoid fractions for the treatment of postoperative hemorrhoid complications: A systematic review and meta-analysis.
Fu H; Guo W; Zhou B; Liu Y; Gao Y; Li M
Phytomedicine; 2022 Sep; 104():154244. PubMed ID: 35752073
[TBL] [Abstract][Full Text] [Related]
5. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
Zagriadskiĭ EA; Bogomazov AM; Golovko EB
Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
[TBL] [Abstract][Full Text] [Related]
6. The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes.
Jiang ZM; Cao JD
Curr Med Res Opin; 2006 Jun; 22(6):1141-7. PubMed ID: 16846547
[TBL] [Abstract][Full Text] [Related]
7. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
8. Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review.
Lohsiriwat V; Sheikh P; Bandolon R; Ren DL; Roslani AC; Schaible K; Freitag A; Martin M; Yaltirik P; Godeberge P
Adv Ther; 2023 Jan; 40(1):117-132. PubMed ID: 36331754
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
10. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease.
Shelygin Y; Krivokapic Z; Frolov SA; Kostarev IV; Astashov VL; Vasiliev SV; Lakhin AV; Rodoman GV; Soloviev AO; Stoyko YM; Khitaryan AG; Nechay IA
Curr Med Res Opin; 2016 Nov; 32(11):1821-1826. PubMed ID: 27404053
[TBL] [Abstract][Full Text] [Related]
11. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
[TBL] [Abstract][Full Text] [Related]
12. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
13. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
[TBL] [Abstract][Full Text] [Related]
14. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of micronized purified flavonoid fractions (MPFF) for haemorrhoids: A systematic review and meta-analysis.
Aziz Z; Huin WK; Badrul Hisham MD; Tang WL; Yaacob S
Complement Ther Med; 2018 Aug; 39():49-55. PubMed ID: 30012392
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.
Dimitroulopoulos D; Tsamakidis K; Xinopoulos D; Karaitianos I; Fotopoulou A; Paraskevas E
Clin Ther; 2005 Jun; 27(6):746-54. PubMed ID: 16117981
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of micronized purified flavonoid fraction: an overview.
Struckmann JR
J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049
[TBL] [Abstract][Full Text] [Related]
18. Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment.
Amaturo A; Meucci M; Mari FS
Acta Biomed; 2020 Mar; 91(1):139-141. PubMed ID: 32191669
[TBL] [Abstract][Full Text] [Related]
19. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
Jantet G
Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
[TBL] [Abstract][Full Text] [Related]
20. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]